Our approach is holistic, focusing on a combination of diet, exercise, behavioral changes, and, when suitable, medication to ensure the best possible outcomes for our patients
We emphasize purity and consistency across all research workflows
Retatrutide clinical trials and preliminary results Eli Lilly, the manufacturer of Retatrutide, completed their Phase II trials and released results in June 2023
New analysis of GLP-1 drugs suggests people who stopped using medications regained 60% of weight lost New research is taking a closer look at what can happen a year or more after people stop taking GLP-1 medications
Our 3D body scan provides a detailed, visual look at your body composition by capturing precise measurements and shape changes over time